Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-006312

Chief Development Officer acquired 9,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Longpre Lara Chief Development Officer 2023-01-31 Grant or award +9,625 106,159 D
Derivatives
Longpre Lara Chief Development Officer 2023-01-31 Grant or award · Stock Option (right to buy) +38,500 38,500 D
Loading xslF345X03/doc4.xml…